chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HCP reported an 18-year-old patient who has already received 3 doses of RECOMBIVAX HB but is non-reactive on an antibody test.; This spontaneous report was received from a physician referring to a 18-year-old patient of unknown gender. The patient's pertinent medical history, drug react6ions/allergies, concurrent conditions and concomitant medications were not reported.       On unknown dates, the patient received 3 doses of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) for prophylaxis (strength, dose, frequency, route of administration, lot # and expiration date were not reported). It was stated that the patient was non-reactive on an antibody test (hepatitis b antibody negative). No additional adverse event (AE) was reported. At the time of reporting, the outcome of the event was unknown.  The causality assessment between the event and hepatitis b vaccine (recombinant)(RECOMBIVAX HB) was not provided.
her 2 sisters received their second dose of GARDASIL 9 on an unknown date last week/they received their first dose of Gardasil 9 in January 2020; This spontaneous report was received from a consumer and refers to a her sister of unknown age. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported.  On an unknown date in January 2020, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dosage, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. The consumer reported that the patient received her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dosage, route of administration, anatomical location, lot number and expiration date were not reported) on an unknown date in February 2022 (reported as "last week") (Inappropriate schedule of product administration).  This is one of several reports reported by the same reporter.; Sender's Comments:  US-009507513-2202USA006120: US-009507513-2203USA002098:
having diarrhea ever since; a runny nose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (having diarrhea ever since) and RHINORRHOEA (a runny nose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (having diarrhea ever since) and RHINORRHOEA (a runny nose). At the time of the report, DIARRHOEA (having diarrhea ever since) and RHINORRHOEA (a runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Child was due for first Covid monovalent vaccine and was mistakenly administered a Bivalent Covid vaccine intended for 6-11 yr olds. No adverse effects reported.  Clinic realized the mistake when child returned for 2nd dose.
pt recv vax 14MAR97 & 15MAR97 pt exp a cold w/runny nose;the cold was treated w/APAP & pediacare;16MAR97 pt exp a low grade fever 101;19MAR97 pt devel diarrhea;
Redness, swelling, heat, pain, hardness of large area between left elbow and shoulder around site of pneumonia injection. (No adverse reaction from flu shot in right arm.)  First night- bands of black and red around swollen area.  Second night - black and red bands were gone, but all other symptoms remained.  Third night - swelling somewhat diminished, redness & hardness significantly diminished, radiating heat is gone, tenderness has replaced pain in arm.
pt recv vax 1APR96 & 26MAR97 pt exp rash;
Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient received both doses of pfizer at outside entity as a nursing home resident.. Patient has PMH significant for advanced age, dementia, CHF, AF.
TESTED POSITIVE  WHEN FULLY VACCINATED PFIZER EUA 18 APRIL 21 - 09 MAY 21
Patient began having R ear numbness and pain one week after having the second dose of Moderna vaccine. Two weeks later, he began having R facial droop and was unable to close his R eye. He went to the ER and was diagnosed with Bell's Palsy.
Left facial nerve tingling; discomfort especially around orbital area and cheek; discomfort especially around orbital area and cheek; Left posterior neck and head discomfort; Left posterior neck and head discomfort; This is a spontaneous report from a contactable Nurse reporting for herself.   A 54-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), intramuscular in left deltoid at hospital on 16Dec2020 08:45 at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included colitis ulcerative as a child, colectomy total 27 years before. The patient previously experienced allergy to IV contrast as hives. Concomitant medication included loperamide hydrochloride (LOMOTIL) and bifidobacterium breve, bifidobacterium infantis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus paracasei, lactobacillus plantarum, streptococcus thermophilus (VSL#3).  The patient experienced left facial nerve tingling, discomfort especially around orbital area and cheek; left posterior neck and head discomfort lasting 60-90 minutes on 16Dec2020 18:00 with outcome of recovered on 16Dec2020. The events resolved on own, no medications taken. Prior to vaccination the patient was not diagnosed with COVID-19 and has not been tested for COVID-19.
joint burning/pain (especially ankles and wrists, felt like swelling, but did not look that way), and all-over body aches.  gone by morning.  Sunday 4/25-5pm-burning around injection site and large, light rash.  somewhat itchy
A report has been received from a Health Professional concerning a 50 year old, Female subject, who had been received Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 27-Oct-2014. It was reported that a 50 year old was administered FLUMIST which started on 27-Oct-2014. The outcome of the event of ADMINISTERED FLUMIST TO a 50 YO is unknown. The report was considered to be non-serious.
On July 5th, I woke up with a scratchy and sore throat and flu-type symptoms, exhaustion. I then took an at home test that was positive. I went and had a PCR test at an Urgent Care. I proceeded to have a productive cough for two weeks and then on July 19th I went to another Urgent Care and received another rapid test and that was a "hard positive". Prescribed an antibiotic. August 1st was the first day that I did not feel flu-like symptoms. I had experienced an abnormal sputum cough, diarrhea, and fatigue, nausea.
The patient is a 72 y.o. male who presented with dyspnea on exertion.  Pt c/o severe breathlessness with minimal exertion that started 2-3 days ago.  He denies dyspnea at rest.  Denies CP.  No fevers or cough.  Has history of CAD.  Was found to be COVID positive.  No hypoxia and no infiltrates on CXR.  He is vaccinated.  "   Hospital Course:   The patient was admitted to the hospital and was evaluated and treated per below.      * Dyspnea on exertion o Dyspnea on exertion with concern about possible angina equivalent. He is Covid positive and fully vaccinated. No IV Remdesivir or steroids initiated on admission. Chest x-ray showed no focal consolidation. Patient reported feeling better following admission with progressive resolution of his shortness of breath. His serial cardiac enzymes remained negative ruling out acute coronary syndrome. Telemetry was uneventful. Echocardiogram was done showing normal ejection fraction. Myoview cardiac stress test was done showing normal study. With patient's symptoms gradually resolving and the absence of chest pain patient was discharged home to follow up on outpatient basis. o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Foot wound. Followed outpatient. Currently on doxycycline. Continue course as prescribed.
Information has been received from a health professional concerning an 8 yr old female who is allergic to amoxicillin, sulfa and gentamicin sulfate (Garamycin) and has no other pertinent medical history who on 27Apr98 was vaccinated SC in the left thigh with a 0m5mL second dose of varicella virus vaccine live (lot 625131/0053H). Concomitant vaccination that day included a second dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot625231/1598E) in her right thigh. Concomitant therapy included diphenhydramine hydrochloride (Benadryl). There was no illness at the time of vaccination. There were no adverse events following prior vaccination. On 17May05 the pt developed chickenpox all over her body. It was reported that the pt had pustules, no scabs, and that she did not have a fever. Unspecified medical attention was sought. There was no treatment. At the time of the report it was not known if the pt had recovered. There was no product quality complaint involved. Additional information has been requested.
Sig stomach and gut cramps to the point of near syncope. Missed half day work. Nausea, lack of appetite. Lasted over 4 hs severe, 12 hs moderate
Chronic hives all over body with no relief towards any medication. Currently dealing with dermatographia (skin writing) that is also very itchy. I take Claritin in the morning, Zyrtec at lunch, Allegra in the evening, and hydroxyzine at bedtime to lessen the symptoms. No prior history of allergies or skin reactions.
Information has been received from a pharmacist concerning a 61 year old female patient with none pertinent medical history and none drug allergies, who on 09-DEC-2011, was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# 671662/1160AA) (exp. 18-OCT-2012). Concomitant therapy included hormones (unspecified). On 13-DEC-2011, the patient developed a burning pain (described as a sunburn like pain, no rash) in her left thigh and back (kidney area) following vaccination with ZOSTAVAX (Merck). The patient contact with the pharmacy on 14-DEC-2011, about the burning pain. The burning pain developed in the evening of 13-DEC-2011, in the left thigh area. On 14-DEC-2011, the burning pain seemed to get slightly better, but on 15-DEC-2011, the burning pain had spread to the left lower back (kidney area). The burning pain was still present in the left thigh on 15-DEC-2011. No treatment was given for adverse events. The patient contacted the pharmacist. At the time of the report the patient's status was not recovered. Follow up information has been received from a pharmacist concerning a patient, professor, with allergy (seasonal only), no illness at time of vaccination and no adverse events following prior vaccinations, who on 09-DEC-2011 at 2:45 PM, was vaccinated with a first dose of ZOSTAVAX (Merck) (SC, left deltoid, dose not reported) (Lot# 671139/1265AA). The pharmacist reported that on 11-DEC-2011 at 4:00 PM, the patient developed sciatic on left leg involving from hip to left ankle, deep muscle pain, and surface burning sensation. Duration until 20-JAN-2012. The patient was treated with OTC analgesic. The pharmacist reported that the patient still have burning in shin area and the rash still not resolved. The pharmacist stated that the patient visited her physician. The pharmacist considered reported adverse experiences to be disabling. At the time of the report the outcome of the patient was not recovered. Additional information has been requested.
localized soreness of arm for 2 days p/vax;a return of soreness in same spot in arm 8 days later followed by nausea, chills, dizziness/vertigo which laste 2 days then subsided;
Patient reports intense soreness in upper arm beginning in shoulder radiating to the elbow, also experienced redness and some inflammation at injections site. She also reports it feeling tight and tender. She contacted the pharmacy at 10am to report effects and we followed up at 7pm. At 7pm the patient reports some tightness, inflammation and tenderness but noted that it is improving.
I have received two COVID Pfizer vaccines. My first dose was on 4/9/21 and my second dose was on 5/7/21. I had mild side effects such as a sore arm and was tired. Today 9/22/21  I went into my clinic for a flu shot. They did not verify my name and did not verify the shot prior to injection. After injection, the clinician filled out my paper work and I noticed that it said COVID. I informed the provider that they had made a mistake. She started worrying saying "you are the patient right?". They were not even aware that I was the wrong patient or that I had been given the wrong drug. They explained to me that they believe I will be fine because some elderly people are getting the COVID vaccine booster dose. I was not given a choice to get the shot.
Upper arm soreness; Muscle soreness; Pain when lifting arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL, LOSARTAN, ATORVASTATIN, VITAMIN supplements, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), HCTZ, RALOXIFENE and IBANDRONATE SODIUM (IBANDRONATE) for an unknown indication.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Feb-2021, the patient experienced AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm).   At the time of the report, AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
I was lethargic the day after with a bad headache. I slept for about 3 hours. A few days later, I developed one large spot of shingles in the center of my back. I took a picture of it and sent it to my doctor. She agreed that it looked like shingles, so I came in for an appointment. She started me on some medicine for the shingles. I applied calamine lotion and some hydrocortisone to the lesion as needed for pain. I took Acetaminophen for pain. The lesion improved after a couple of weeks and it did not spread. It reoccurred again 8 weeks later with more lesions. I took another picture for my doctor and she prescribed the same medicine. I basically repeated what I did the first time. She told me to come in if it got any worse. It took about 3-4 weeks for them to go away.  I got swelling at the injection site. I had a swollen lymph node on the right side of my arm. It was very painful.
pt recv vax 17JUL96 & 7AUG96 exp pruritus progressing to a maculopapular rash over entire body;An ER or MD visit was required;MD reported that daughter appeared to have had a delayed hypersensitivity rxn;
Her lungs were full of fluid; Few days after first dose left sided chest achiness.; First dose the next morning she was wheezing and had to take a breathing treatment, resolved; At the injection site both times, she had a lot of injection pain.; This is a spontaneous report received from a contactable consumer or other non hcp. The contact-able consumer described events for both doses of bnt162b2. This report describes events for the first dose. A 59-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EW0217) via an unspecified route of administration in Arm Left on 06Jun2021 as single dose for covid-19 immunisation. Medical history included food allergy, allergy to drugs, allergy to animal cats, pollen, allergy to plants trees, grass, asthma from since she was 11 and unknown if ongoing, thyroid disorder from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine (LEVOTHYROXINE) taken for thyroid disorder, start and stop date were not reported; salbutamol (ALBUTEROL HFA) taken for asthma, start and stop date were not reported. The patient underwent lab tests and procedures which included computerised tomogram: ruptured on unspecified date. The patient experienced at the injection site both times, she had a lot of injection pain on 06Jun2021, first dose the next morning she was wheezing and had to take a breathing treatment resolved on 07Jun2021, her lungs were full of fluid, few days after first dose left sided chest achiness on an unspecified date. The clinical outcome of the event wheezing was resolved, and other events was unknown.  No follow-up attempts are possible. No further information is expected.
Symptoms started and complete exhaustion. Then still neck started, massive headaches. Blurred vision, stabbing pains in head. Temples felt swollen. Numbness on right side of body. Ringing in ears. Brain felt like it had icy hot on it. Vision floaters. Massive brain fog to where I couldn?t form sentences.  Dizzy. Pain in diff parts of brain at random times. Scalp felt squishy. Pain in neck glands. Random shaking in left arm of vaccination side. Close fainting episodes, everything went black and had to grab onto something to keep from falling down.
13:40 C/O soreness at injection site.  Left deltoid flushing to neck and chest noted.  T:99.2F Temperature decreased T 98.6F after 20 min.  Pt was monitored for 45 min. 14:16 Pt was released
Immediately after shot severe arm pain where had shot from 1 hour after shot did not feel well. Tired. By the evening headache. Body aches. Stomach ache. Feverish. By next day in bed with same flu like symptoms and red rash on both face, cheeks and fever of 101 at 5 pm. No appetite. Woke up next day extreme dry mouth. Next day being today March 9. No more symptoms except tired from ordeal.
I developed a big red patch on my arm. It lasted about a week. It looked like a big square. On the evening of 04/30/2021 I developed a migraine. On May 1st I called my doctor to make sure I could take my migraine after getting vaccinated and was told yes. I took that and the migraine was resolved. I also had a temperature of 99.
Pt reported fever following day after vaccine admin. Today reported swelling, warm to touch, pain/stiffness, redness along entire back of upper arm.
I fainted in the shower and was found confused and incoherent.  I was rushed by ambulance to the ER. They performed a CT scan of my brain that looked ok.  My serum lactate was elevated and the doctor suspects that I may have had a seizure.  I will be following up with neurologist soon.  I have no reason to think that this incident is related to the COVID vaccine.
APAP given through Wednesday;wakened from nap Wednesday evening;t105.4, hands & feet cold blue;vomited, sl sz;tepid bath & fever dec;
About 12 hours after receiving the shot I developed flu-like symptoms including chills, fever, muscle aches and extreme fatigue that lasted around 24 hours. The pain at the injection site radiated out into may back, chest and neck, resulting in it being difficult to move the right side of my body for around 24 hours. After these symptoms subsided I felt a constant heaviness and "whooshing" sound/sensation in my neck, head and ears for about 4-5 days. After this all symptoms subsided and I felt fine.
The vaccine was not injected into the muscle as prescribed. The nurse pinched up the fat on my arm with a short needle. My upper arm swelled almost to the size of a baseball and was red and painful for over one week. I think it was administered SQ although intended to be IM.  I am a nurse and thought to myself at the time of injection that the proper technique for administering the shot was not followed, but thought perhaps I could be wrong and the extra swelling might be normal with the second injection.  My first injection was in left arm and did not swell and was only sore for a few days. If administered SQ, will the vaccine dose be effective?
This spontaneous report was received from a registered nurse refers to a 8 weeks old male patient. On 23-OCT-2014, the patient was vaccinated with a dose of improperly stored ROTATEQ lot # K001716, expiry date 25-FEB-2016) oral. The outcome of the event was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Rapid, irregular heart rate, diagnosed as atrial fibrillation. Unresolved.
Feeling of waves going down nerves in legs and causing tingling and fuzzy feeling 5 - 10 minutes after receiving injection.  Had brain fog for remainder of day, just so tired and head feeling fuzzy and unfocused, and very lightheaded.  Could not get warm, legs were freezing, had chills, but not fever all day, although temperature slightly elevated...98 .7 - 99,  as opposed to usual 96.7.  Legs and feet were tingly and felt numb all day and night.  Slept horribly, bobody felt electrified all day.  Chills gone on the 24th but had same nervous feelings and heart rate elevated.  Pulse normally in 74- 84 range was 98 - 100, and would go up to 115 if moved across room to sit.  Felt odd and heart felt like it was racing.  Felt shaky and cold/hot all day.  On the 25th went to MD, reported symptoms which started to subside as day went on.
This spontaneous report was received from a physician referring to a 4-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 09-AUG-2017, the patient was vaccinated with improperly stored ROTATEQ orally, lot # M041184 with expiration date on 31-MAY-2018 for prophylaxis (dose was not provided). The vaccine was exposed to a temperature of 49 Fahrenheit degrees for 16 hours on 20-MAY-2017, 17-JUN-2017 and 21-JUN-2017. The vaccine was exposed to a temperature of 48 Fahrenheit degrees for 16 hours on 27-MAY-2017, 02-JUN-2017 and 03-JUN-2017. The vaccine was exposed to a temperature of 47 Fahrenheit degrees for 16 hours on 09-JUN-2017, 13-JUN-2017, 22-JUN-2017, 23-JUN-2017, 28-JUN-2017 and 29-JUN-2017 and for 70 hours on 30-MAY-2017. The vaccine was exposed to a temperature of 35 Fahrenheit degrees for 16 hours on 27-JUN-2017, 20-JUL-2017 and 28-JUL-2017 and for 46 hours on 17-JUL-2017 and 26-JUN-2017. The vaccine was exposed to a temperature of 34 Fahrenheit degrees for 16 hours since 29-JUN-2017 until 01-JUL-2017, on 03-JUL-2017, 06-JUL-2017, 07-JUL-2017, 19-JUL-2017 and 26-JUL-2017, for 40 hours on 05-JUL-2017 and for 46 hours on 10-JUL-2017. The vaccine was exposed to a temperature of 33 Fahrenheit degrees for 16 hours on 08-JUL-2017 and since 11-JUL-2017 until 15-JUL-2017 and on 27-JUL-2017. The vaccine was also exposed to a temperature of 32 Fahrenheit degrees for 16 hours on 22-JUL-2017. Additionally, it was reported that digital data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-1709USA012770: US-009507513-1709USA007325: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA012764: US-009507513-1709USA012766: US-009507513-1711USA003163: US-009507513-1711USA003164: US-009507513-1711USA003162: US-009507513-1711USA003161: US-009507513-1711USA003160: US-009507513-1711USA003159: US-009507513-1709USA012767: US-009507513-1711USA003165: US-009507513-1711USA003158: